Live market screen
Commercial Space Company Risk / Opportunity Ranking
Opportunity/risk view across launch, satellites, SAR, earth observation, defense demand, financing events, and execution risk.
Updated June 27, 2026
Opportunity view
Showing rows 181-200 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 181 | Earth Eye Co lowweak | Opp 2 Risk 3 | Thesis: The reviewed sources only indicates Earth Eye Co is a Chinese private company associated with the TEE-01B surveillance satellite used for imaging and surveillance. This suggests some asset relevance in Earth observation, but there is no direct business traction or positive catalyst evidence available. Why now: Why now is weak because there are no available post-recent evidence window evidence, no article summaries, and no clear near- or long-horizon catalyst beyond generic association with a surveillance satellite. Caveats: Membership rationale cites article IDs and, but the reviewed sources provide no. Company is private and evidence coverage inside the recent evidence window is empty. |
| 182 | Exquadrum, Inc. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale describes Exquadrum as a rocket-maker acquired by Mach Industries, which at least indicates strategic relevance to launch/propulsion capabilities if the acquisition meaningfully advances commercialization (: no provided in reviewed sources). Why now: No retained evidence establishes current milestone timing or post-acquisition integration progress, so there is no strong why-now supported in these reviewed sources. Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Acquisition context is weaker than direct operating evidence. |
| 183 | Fergani Space lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence rationale suggests Fergani Space launched a fifth test satellite into LEO with communications and navigation capabilities, which could indicate technical progress if still current, but no direct post-recent evidence window evidence are available to support a durable 1 year+ opportunity thesis. Why now: There is no credible 'why now' catalyst in the reviewed sources because articles after recent evidence window and evidence after recent evidence window are both zero for this company. The only cited support is older or excluded from the active evidence set: article, referenced in the membership rationale, was outside the kept recent evidence window according to the company coverage report. Caveats: No evidence were available after recent evidence filtering. No representative articles or additional_company_articles were provided. Membership rationale is weaker than direct event/fact evidence. |
| 184 | Filtronic PLC lowweak | Opp 2 Risk 1 | Thesis: Older reviewed sources context says Filtronic is in a space/satellite communications context and has a SpaceX deal via article, which could be positive if current, but there is no retained in-window direct positive evidence with to justify a stronger ranking. Why now: There is no evidenced near-term or durable why-now catalyst inside the retained 90-day evidence window. Caveats: Reviewed evidence references but provides no representative article. Potentially positive older context may be stale or superseded; recency cannot be validated. No retained evidence after recent evidence window. |
| 185 | GalaxEye Space lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources membership rationale describes GalaxEye as launching Mission Drishti, an OptoSAR satellite with defense and disaster-response use cases, which is strategically interesting, but no within the recent evidence window direct evidence is available to support a stronger ranked opportunity. Why now: There is no within the recent evidence window evidence available in these reviewed sources for GalaxEye Space; timing and maturity of current milestones cannot be confirmed from reviewed sources evidence. Caveats: Membership rationale cites article IDs and, but their article content is not provided here for citation. Evidence recent evidence review shows 0 kept rows. This entity may overlap with GalaxEye Space Solutions Private Ltd, but the output contract requires scoring both separately. |
| 186 | GALVANY lowweak | Opp 2 Risk 2 | Thesis: The membership rationale says GALVANY raised a €10M seed in a European tech funding roundup, which is at least a financing signal that could support future execution. However, the reviewed sources explicitly says funding alone is insufficient without a clear space linkage, and there are no available direct evidence after recent evidence window. Why now: The only possible timing angle is the referenced seed raise in the membership rationale, but no -backed available evidence remains after the recent evidence filter, so recency and impact cannot be validated for scoring. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Funding context does not prove target-cohort fit. |
| 187 | GEOST lowweak | Opp 2 Risk 2 | Thesis: GEOST may retain strategic relevance through its cited prototype development role in space domain awareness and the note that it is now Rocket Lab Optical Systems after acquisition, but the reviewed sources provide no retained recent evidence window-window evidence to support a current standalone upside thesis. Why now: There is no retained within the recent evidence window evidence. Any thesis would rely on older context referenced in the membership rationale, which is insufficient for a stronger rank. Caveats: Reviewed evidence references acquired-business context rather than current standalone operations. No representative articles or retained evidence are included. Low scores reflect missing timely evidence, not a directional call on the business. |
| 188 | GHGSat lowweak | Opp 2 Risk 2 | Thesis: GHGSat likely has strategic relevance as a commercial greenhouse-gas monitoring satellite company, but the reviewed sources includes no available dated evidence to support a stronger opportunity ranking. Why now: The reviewed sources offers no recent evidence window-supported event timing for a why-now view. Caveats: The membership rationale says GHGSat is the world's leading commercial greenhouse gas monitoring satellite company, but the supporting article content is not available here for ranking use. Absence of negative evidence is not positive evidence. |
| 189 | Globalstar lowweak | Opp 2 Risk 2 | Thesis: Globalstar is described in membership rationale as a satellite communications and direct-to-device company, but the reviewed sources includes no available within the recent evidence window positive evidence to support a stronger ranked opportunity view. Why now: No within the recent evidence window evidence were available for Globalstar in these reviewed sources, so there is no current catalyst basis to elevate either opportunity or risk. Caveats: Evidence recent evidence review shows 0 kept rows after the 90-day cutoff. Membership rationale cites article IDs, and: but those article contents are not provided here for direct factual citation. Public company status does not improve ranking without directional evidence. |
| 190 | Guoxing Aerospace Technology lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale says Tencent partners with Guoxing Aerospace for Star Computing AI cloud in an article about space-based AI computing, which could imply exposure to a longer-horizon emerging segment if substantiated by direct evidence (: no provided in reviewed sources). Why now: Space-based AI computing could be strategically relevant over 1 year+, but the reviewed sources provide no retained dated evidence to confirm partnership scope, timing, or commercial milestones. Caveats: No current evidence is provided for the cited support article in the reviewed sources. Coverage debug shows articles after recent evidence window = 0 and evidence after recent evidence window = 0. Partnership mention alone is insufficient to prove durable company impact. |
| 191 | HawkEye 360, Inc. lowweak | Opp 2 Risk 1 | Thesis: The reviewed sources membership rationale says HawkEye 360 provides RF intelligence/data services and has government-linked business, which could support a durable demand thesis, but no within the recent evidence window evidence or article summaries are available to justify a stronger score. Why now: There is no available post-recent evidence window evidence in the reviewed sources to establish a current catalyst or changed business state. Caveats: No evidence available after recent evidence window. Cannot rely on membership rationale alone for direction. |
| 192 | HawkEye 360, Inc. lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources indicates HawkEye 360 is a space intelligence company with a satellite constellation and government-contract exposure, which could be attractive over a multi-year horizon if contract flow and constellation utilization continue. Why now: The only retained dated item is an April 5, 2026 supporting article context entry stating HawkEye 360 is a data analytics company developing space-based radio frequency mapping and a satellite constellation startup: That is too weak to establish a strong current catalyst. Caveats: Only weak supporting article context is retained after recent evidence window; no direct event/fact evidence is available. Phase2 rationale mentions 30+ satellites and government contracts, but the reviewed sources does not provide those source articles in detail here. |
| 193 | Innoseis lowweak | Opp 2 Risk 1 | Thesis: Innoseis has the strongest limited positive context in this screen because the membership rationale says it raised €6M and has applications in space exploration, with technology selected for future Moon measurements, which could support a long-horizon opportunity if substantiated by direct evidence (: unavailable in reviewed sources). However, the reviewed sources have no direct positive evidence within the recent evidence window, so the thesis remains low confidence. Why now: Potentially relevant because the article context references funding and lunar-measurement selection, but the reviewed sources provide no dated evidence or, so recency and sequence cannot be verified beyond the membership rationale tied to Caveats: No current evidence is provided for cited Zero evidence available after recent evidence window despite the membership rationale. Funding and technology-selection references are article-context level only here. |
| 194 | Intelsat lowweak | Opp 2 Risk 1 | Thesis: The only positive indication in the reviewed sources are membership rationale stating Intelsat participated with Viasat in a Space Force mini-GEO satellite award, which could support a long-horizon government satcom opportunity if current and material, but no direct evidence or article summaries are available after the 90-day recent evidence window. Why now: Why now is weak because coverage data shows 0 article IDs after recent evidence window and 0 evidence available after recent evidence window, so timing and durability cannot be validated from these reviewed sources. Caveats: Membership rationale cites article IDs: and: but the reviewed sources provide no or summaries for them. Evidence recent evidence review shows kept_rows 0 and undated_rows_kept 0, so there is no usable direct evidence inside the ranking window. Cannot treat cohort membership as thesis attractiveness. |
| 195 | Intelsat General lowweak | Opp 2 Risk 2 | Thesis: Reviewed evidence membership rationale says Intelsat General was tied to a Space Force PTS-G satellite contract, which could support long-horizon defense-space opportunity, but no post-recent evidence window evidence or article summaries were available for scoring. Why now: Why-now support is weak because coverage data shows zero article/evidence after the 90-day recent evidence window, so recency for the cited contract context cannot be validated from available evidence. Caveats: Phase2 membership rationale references: but no representative article or evidence row is available after recent evidence window for direct citation. Coverage data reports articles after recent evidence window = 0 and evidence after recent evidence window = 0. Scored low due to evidence absence, not due to negative business evidence. |
| 196 | iQPS lowweak | Opp 2 Risk 1 | Thesis: Membership rationale says Rocket Lab secured a multi-launch agreement with iQPS for SAR satellites, which suggests iQPS may have meaningful constellation deployment activity over a 1 year+ horizon if current. Why now: Why now is limited because the support is only referenced through membership rationale citing articles and, but the reviewed sources provide no or retained evidence after recent evidence window. Caveats: No or article summaries are provided for cited support articles and. Coverage data shows zero retained evidence after recent evidence window. Potentially interesting launch-agreement signal cannot be scored highly without direct reviewed sources evidence. |
| 197 | Jacobs lowweak | Opp 2 Risk 2 | Thesis: Jacobs has evidence of a large Space Force Range Contract award worth up to $4 billion over 10 years, which would ordinarily support a positive thesis, but the relevant articles are dated June 3, 2025 and are outside the reviewed sources' 90-day recent evidence window, so current opportunity support is weak in these reviewed sources. Why now: Why now is weak because the contract evidence is older. The reviewed sources cites Space Force and SpaceNews articles dated June 3, 2025, which are outside the 90-day evidence window Caveats: Contract evidence exists but falls outside the selected 90-day recent evidence window. No direct positive or negative evidence remain after recent evidence filtering. |
| 198 | Jio Platforms lowweak | Opp 2 Risk 2 | Thesis: The reviewed sources rationale says Jio Platforms is the vehicle for Reliance's planned multi-billion-dollar LEO satellite communications entry and planned network to compete with Starlink and Kuiper, which suggests long-horizon optionality if execution proceeds, but no underlying article evidence is provided in these reviewed sources output. Why now: Why now is not well supported in the served evidence because no representative articles or direct evidence are available after recent evidence window despite the membership rationale referencing article IDs, and Caveats: No representative articles or direct evidence are included in the reviewed sources output. Membership rationale is not a substitute for direct thesis evidence. Recency and event sequence cannot be judged from the missing article details. |
| 199 | Karman Holdings Inc. lowweak | Opp 2 Risk 1 | Thesis: Karman Holdings has modest contextual upside because the membership rationale says the reviewed sources placed it in broad space/defense and supply-chain articles and provided revenue facts, which may indicate operating scale or relevance to a durable strategic cycle, unavailable in reviewed sources). But there is no available direct positive evidence after recent evidence window, so this does not support more than a low opportunity score. Why now: Why now is weak because there are no retained evidence after the 90-day cutoff date of March 29, 2026, despite multiple older considered articles. Caveats: No current evidence is provided for and. Revenue facts are referenced only in the membership rationale, not available as direct evidence. Broad supply-chain context is weaker than company-specific contract or product evidence. |
| 200 | Korea Aerospace Industries (KAI) lowweak | Opp 2 Risk 2 | Thesis: Limited opportunity based only on the reviewed sources membership rationale that identifies CAS500-2 as an Earth observation satellite for KAI, indicating confirmed participation in a qualifying satellite activity but not providing a new catalyst, contract, backlog, or financial inflection. Why now: Why now is weak because the reviewed sources say one article supported membership, article ID: but no, timing detail, or direct evidence were available after recent evidence window. Caveats: No direct evidence or article summaries were available after recent evidence window. Membership support references article ID: without a in the reviewed sources. |
Risk view
Showing rows 401-420 of 438; 20 rows per page.
| Rank | Company | Score | Thesis / Evidence |
|---|---|---|---|
| 401 | ULA lowweak | Opp 1 Risk 1 | Thesis: There is no retained 90-day negative evidence to support a material risk case. Why now: Coverage data shows zero retained article IDs and evidence after the recent evidence filter, so there is no recent thesis-driving evidence in the reviewed sources. Caveats: Only membership-level context is present in the served reviewed sources. No direct event, fact, or article-context evidence remains within the recent evidence window. Direction cannot be inferred from category membership alone. |
| 402 | Uncovr lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is available, but absence of negative evidence is not a positive thesis. Why now: The only described context is a funding-roundup article referenced in phase2 rationale, but no post-recent evidence window evidence or are provided for thesis use. Caveats: Phase2 rationale says Uncovr was listed as having raised $7M in article: but no was provided in the reviewed sources. Despite support_counts mentioning dated event/facts, the company-level available evidence arrays are empty and coverage data shows evidence after recent evidence window = 0. Broad funding roundup context is weaker than direct company-specific event evidence. |
| 403 | United Launch Alliance lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is provided in the reviewed sources after recent evidence filtering, so a negative thesis is not established either. Why now: Why now is unsupported because the reviewed sources contain no surviving article or evidence after the selected recent evidence window; business-state or catalyst timing cannot be judged from the provided materials. Caveats: Zero evidence survived after recent evidence filtering. Company membership in the cohort is not thesis attractiveness. No dated catalyst, performance update, or direct risk item is included. |
| 404 | Univity lowweak | Opp 1 Risk 1 | Thesis: A large planned constellation and early-stage buildout could imply execution risk, but the reviewed sources provide no direct adverse evidence within the available evidence set. Why now: No usable within the recent evidence window evidence were available after filtering; recency-based thesis formation is therefore not supported in these reviewed sources. Caveats: Coverage after recent evidence window is effectively empty in these reviewed sources. Membership rationale is not directional proof. |
| 405 | Vantor lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained in the reviewed sources, so there is no evidence-based risk thesis at present. Why now: Why now is weak because the reviewed sources contain no retained post-cutoff directional evidence. Caveats: Coverage debug shows articles after recent evidence window 0 and evidence after recent evidence window 0. Membership rationale references article IDs without and cannot be cited directly here. |
| 406 | Varda Space Industries lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources also contains no retained 90-day direct negative evidence, so there is not enough support for a material adverse thesis either. Why now: No within the recent evidence window company-specific evidence were available after filtering; articles after recent evidence window and evidence after recent evidence window are both zero in coverage data, so recency-based thesis formation is not supported in these reviewed sources. Caveats: 12 articles were considered historically, but zero article IDs remained after the 90-day recent evidence filter. Membership rationale cites older support article IDs but those underlying evidence are not retained in the served reviewed sources. Scores are constrained by evidence absence, not by a documented negative business development. |
| 407 | Veact lowweak | Opp 0 Risk 1 | Thesis: No material adverse thesis is supported either; the main issue is insufficient evidence rather than identified business deterioration. Why now: No why-now catalyst is supported because the reviewed sources contain no post-recent evidence window evidence. Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. A broad funding roundup is not enough to establish thesis direction. Coverage data shows articles after recent evidence window = 0. |
| 408 | Venturi Astrolab lowweak | Opp 1 Risk 1 | Thesis: No material adverse evidence is retained in these reviewed sources. Why now: Why now is weak because despite 30 articles considered, coverage data shows articles after recent evidence window of 0 and evidence recent evidence review kept_rows of 0, so the reviewed sources does not preserve dated supporting evidence inside the 90-day window. Caveats: Phase-2 rationale cannot substitute for cited article evidence because are absent. No direct positive or negative evidence arrays are populated. Low scores are driven by evidence retention limits in these reviewed sources. |
| 409 | Virgin Galactic Holdings, Inc. lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources does not provide direct negative evidence inside the scoring fields, so no material adverse thesis is supportable here. Why now: The phase2 rationale references three article IDs, but the reviewed sources includes no representative article summaries or evidence to cite for a dated catalyst. Coverage data shows zero article IDs after recent evidence window and zero available evidence, so the current-state thesis is unsupported by reviewed sources detail. Caveats: Do not infer direction from company identity or sector relevance alone. Phase2 membership support cannot substitute for direct thesis evidence. |
| 410 | Volteum lowweak | Opp 0 Risk 1 | Thesis: No direct negative evidence is available; current ranking is constrained by missing evidence rather than identified downside events. Why now: No catalyst is supported in the reviewed sources due to zero post-recent evidence window evidence. Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. Funding-roundup presence alone is not directional proof. Evidence strength remains minimal. |
| 411 | Vyoma GmbH lowweak | Opp 1 Risk 1 | Thesis: No material negative evidence is supplied after recent evidence filtering, so a risk thesis is not supported either. Why now: Why now is unsupported because the reviewed sources contain no surviving evidence after recent evidence filtering; timing and business-state changes cannot be validated from the provided material. Caveats: Zero evidence after recent evidence filtering. Membership rationale alone is not sufficient for directional scoring. No direct dated catalyst or adverse development is provided. |
| 412 | Windward lowweak | Opp 2 Risk 1 | Thesis: No material adverse evidence is retained. The main risk is classification ambiguity and weak grounding, not a documented negative event. Why now: There is no validated within the recent evidence window catalyst. The only support cited is phase-2 rationale referencing, and without or retained evidence. Caveats: Reviewed evidence language distinguishes maritime domain awareness from space domain awareness. No retained article summaries or evidence are available after recent evidence window. Context-only relations must not be propagated into stronger thesis claims. |
| 413 | Windward Ltd. lowweak | Opp 1 Risk 1 | Thesis: There is no direct negative evidence. The only notable issue is that the available mention is relation context, which is insufficient for a real risk thesis. Why now: No catalyst is established. Coverage debug shows 27 article IDs considered but 0 after recent evidence window and 0 evidence available. Caveats: Membership rationale references article ID: but no is provided in the reviewed sources, so it cannot be cited as factual scoring evidence under the the evidence standard. Relation context is explicitly weaker and not valid counterparty propagation evidence. |
| 414 | WISeKey International Holding Ltd lowweak | Opp 1 Risk 1 | Thesis: The reviewed sources provide no retained within the recent evidence window direct negative evidence to support a risk thesis. Why now: There are zero available evidence after recent evidence window for ranking, so no evidence-backed timing signal is available. Caveats: Membership support mentions 21 LEO satellites launched and operational space-related infrastructure, but those claims are not accompanied here by retained ranking evidence or article. Without dated evidence inside the recent evidence window, score should remain low-conviction. |
| 415 | York Space Systems lowweak | Opp 1 Risk 1 | Thesis: No retained within the recent evidence window negative evidence was available, so the reviewed sources does not support a material risk thesis. Why now: The reviewed sources have no retained dated evidence after the 90-day recent evidence window, so there is no citable timing edge for a 1 year+ ranking. Caveats: Coverage is effectively empty after recent evidence window: articles after recent evidence window = 0 and evidence after recent evidence window = 0. Membership rationale cites article IDs and, but no or retained evidence text are provided here. Later-dated evidence could supersede older listing or contract-status claims, but no such retained evidence exists in these reviewed sources. |
| 416 | York Space Systems lowweak | Opp 1 Risk 1 | Thesis: There is no retained adverse evidence in the active recent evidence window, so only a minimal risk score is warranted. Why now: Although membership support cites articles, and: no representative summaries or retained evidence are included here, leaving no current catalyst basis. Caveats: 54 articles considered, but 0 retained after recent evidence filtering. Cannot elevate based on membership rationale alone. |
| 417 | Zaro lowweak | Opp 0 Risk 1 | Thesis: No reviewed sources-supported negative thesis is available either; the issue is missing evidence rather than documented adverse developments. Why now: There is no current or durable catalyst supported by the reviewed sources because no evidence survived into the available post-recent evidence window set. Caveats: Phase2 rationale references article: but no was provided in the reviewed sources. General funding-roundup context is weaker than direct event or fact evidence. Coverage remains insufficient for a directional call. |
| 418 | Zoove Space lowweak | Opp 2 Risk 1 | Thesis: No direct negative evidence is supplied. Main risk is that accelerator participation alone is weak support for a durable commercial thesis. Why now: The reviewed sources offers no in-window evidence to confirm timing beyond the phase-2 rationale, so the current catalyst strength is limited. Caveats: No evidence remained after the 90-day recent evidence window. Accelerator selection is a weak signal relative to financing, contracts, or operating milestones. No direct dated article is available in the reviewed sources body. |
| 419 | Akashalabdhi lowweak | Opp 0 Risk 0 | Thesis: No negative thesis is supportable because the reviewed sources contain no direct negative evidence for Akashalabdhi within the recent evidence window. Why now: There is no visible near-term or long-horizon company-specific catalyst in the reviewed sources. The membership review explicitly says the only included article does not mention Akashalabdhi in the visible summary, and coverage debug shows zero articles and zero evidence after recent evidence window. Caveats: No current evidence is provided in the reviewed sources for the cited membership-support article. Evidence recent evidence review shows 0 kept rows after the March 29, 2026 cutoff. The reviewed sources itself says visible evidence is insufficient to determine even qualifying membership. |
| 420 | Amentum Holdings Inc. lowweak | Opp 0 Risk 0 | Thesis: No negative thesis is supportable from retained reviewed sources evidence because there are no direct negative evidence and no articles retained after the 90-day recent evidence window. Why now: No current catalyst is evidenced in the retained reviewed sources. Coverage debug shows zero article IDs after recent evidence window and zero evidence after recent evidence window despite large historical mention volume. Caveats: Phase-2 rationale references article IDs and, but no article summaries or retained evidence are included here. Historical aerospace exposure does not create a current directional thesis without retained evidence. |